Compared with wild-type diabetic mice, TLR4 knockout mice exhibited improvements in diabetic retinopathy due to inhibition of the NF-kB signaling pathway and downstream inflammation, as well as downregulation of the expression of VEGF and GFAP [50]. Here, GFAP is linked to diabetic retinopathy.